Devanshu Singla

JM Financial starts coverage on KPR Mill with 'Buy'; check target price

JM Financial has set a target price of ₹1,215 per share, implying an upside potential of 21 per cent

Largecaps to outperform in 2026 as SMID valuations look stretched: BofA Sec

Bank of America (BofA) Securities said it continues to prefer largecaps over small and midcaps (SMIDs) in CY26 as valuations remain elevated and risks are skewed to the downside

Largecaps to outperform in 2026 as SMID valuations look stretched: BofA

Bank of America (BofA) Securities said it continues to prefer largecaps over small and midcaps (SMIDs) in CY26 as valuations remain elevated and risks are skewed to the downside

Largecaps to outperform in 2026 as SMID valuations look stretched: BofA

Bank of America (BofA) Securities said it continues to prefer largecaps over small and midcaps (SMIDs) in CY26 as valuations remain elevated and risks are skewed to the downside

Largecaps to outperform in 2026 as SMID valuations look stretched: BofA

Bank of America (BofA) Securities said it continues to prefer largecaps over small and midcaps (SMIDs) in CY26 as valuations remain elevated and risks are skewed to the downside

Meesho IPO booked 3x on strong demand; should you bid too? Analysts weigh

Analysts highlight Meesho's zero-commission, asset-light business model, coupled with its multi-sided marketplace and logistics network

Wakefit IPO: D2C growth story, key risks ahead, what investors should know

According to the RHP, Wakefit's performance is heavily dependent on its "Wakefit" brand, under which it sells mattresses, furniture and home furnishings

Meesho vs Aequs vs Vidya Wires IPO: Which one should you bet on?

Analysts remain largely positive on Meesho IPO and Vidya Wires IPO, citing strong growth prospects and operational efficiency, while views on Aequs IPO are cautious

Vidya Wires IPO opens tomorrow: Bid or skip? Here's what experts suggest

The unlisted shares of Vidya Wires were trading at ₹57, commanding a grey market premium of ₹5 or 9.6 per cent on Tuesday

Meesho IPO opens Dec 3: Analysts recommend long-term buy; should you bid?

Analysts at SBI Securities and Arihant Capital have recommended that investors subscribe to the Meesho IPO with a long-term perspective.

Aequs IPO opens Dec 3: Know key strengths, risks before you invest

Aequs IPO will be offered at a price band of ₹118 to ₹124 per share and a lot size of 120 shares

Meesho IPO to unlock ₹1,020 crore bonanza for founders, early backers

Meesho has set the price band for its IPO in the range of ₹105 to ₹111 per cent, valuing it around ₹50,095.75 crore

Axis Securities starts coverage on Elecon Engg with 'Buy'; check target

Elecon has built a strong global presence through subsidiaries in Europe and the United States, strengthened further by the Benzlers-Radicon acquisition

Why is JM Financial upbeat on Belrise Industries? Starts coverage with Buy

JM Financial has set a target price of ₹215 for Belrise Industries stock, valuing it at 25x FY28E P/E

Building materials to revive in H2, says Motilal Oswal; top stock bets here

MOFSL has initiated coverage on Century Plyboards with a 'Buy' rating and Cera Sanitaryware with a 'Neutral' stance

HDFC Securities starts coverage on Eureka Forbes with 'Buy'; check target

HDFC Securities expects Eureka Forbes to deliver strong growth over FY25-28, with revenue, Ebitda, and profit rising at a CAGR of 14 per cent, 23 per cent, and 27 per cent, respectively

Siemens Energy Q4 nos shine; analysts upbeat on strong order book, margins

Siemens Energy India's revenue from operations jumped 27 per cent year-on-year (Y-o-Y) to ₹2,646 crore, compared to 2,09 crore in the year-ago period

Missed Groww? These 3 IPOs also doubled investors' money in 2025

Groww is well placed to benefit from India's rising culture of financialisation and retail investing, even as the broader brokerage industry faces near-term regulatory headwinds

Is Pricol the next big winner? SBI Securities decodes; check target price

SBI Securities expects Pricol's revenue, Ebitda, and PAT to grow at 31 per cent, 33 per cent, and 36 per cent CAGR, respectively, over FY25-27

Sudeep Pharma IPO opens Nov 21: Know key strengths, risks before you invest

Sudeep Pharma IPO will be offered at a price band of ₹563 to ₹593 per share